Skip to contentK
Kewaunee Scientific Corp
K
KEQUKewaunee Scientific Corp Q3 2023 · 10-Q
Revenue$60.82M$60.82M+49.7% vs Q3 2022 Net Income$723.00K$723.00KN/M vs Q3 2022 EPS Diluted$0.25$0.25N/M vs Q3 2022 Gross Profit$10,330,000+83.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kewaunee Scientific Corp · CIK 55529 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,961,000N/M Free Cash Flowderived-$3,604,000N/M Margins · derivedGross margin17.0%+3.1 pt vs Q3 2022
Operating margin3.8%+5.9 pt vs Q3 2022
Net margin1.2%+4.4 pt vs Q3 2022
ended Jan 31, 2023 · filed Mar 10, 2023 · 38 d after period end